Providing members with timely and relevant news, perspectives, opportunities, and calls to action.
April 14, 2026
The Ìý(JACS) has expanded its topic-specific collections to include two new options for finding specific content related to your areas of interest or research: Opioids and Pain Management and Geriatric Surgery and Palliative Care.
April 14, 2026
I had the distinct privilege of representing the ACS at the combined Annual Meeting of the Montana-Wyoming, Idaho, and Utah Chapters. The meeting, February 19–22, at the beautiful Hotel Terra in picturesque Jackson Hole, Wyoming, brought together a geographically expansive and professionally diverse group of surgeons whose commitment to their patients, communities, and profession was evident throughout.
There is a pithy saying in pediatric surgery that, in many ways, defines the discipline—“children aren’t just little adults.â€1 Children have unique physiology, operative demands, psychological and social needs, and other distinctions from adult populations that can necessitate the specialized expertise of a pediatric surgeon.
Read this week's entire issue for the latest news on the ACS and the field of surgery.
Go to your MyCME Portal today and verify your ABS ID and date of birth on the Board Certification Tab so you can have your CME data automatically transmitted to the ABS via ACCME.
The ACS Quality, Safety & Cancer Conference (QSCC), July 30–August 2 in Orlando, Florida, debuts a reimagined meeting experience that integrates quality, safety, and multidisciplinary care teams. The program is designed to deliver deeper insights, stronger professional connections, and practical strategies that improve patient outcomes and institutional performance. For professionals whose work touches surgical and cancer care, whether delivering care in the OR, leading quality initiatives, managing programs, or guiding institutional strategy, QSCC provides a dedicated forum for learning, collaboration, and innovation.
Although portal vein thrombosis (PVT) is well-characterized in the pretransplant setting, de novo PVT after liver transplantation (LT) remains poorly defined, with little known about its incidence, timing patterns, or impact on long-term outcomes in adult deceased-donor LT. Listen to Drs. Omar Alomar and Natnael Doilicho discuss , which found that de novo PVT can be a significant driver of postoperative morbidity, mortality, and organ rejection, and that closer surveillance and study are needed for this underrecognized complication.